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General methods
Commercially available reagents were used without further purification.
N,N-di-n-butylformamide dimethyl acetal was synthesized from N,N-dimethylformamide
dimethyl acetal according to the literature procedure. 1 2'-Deoxy-5-methylisocytidine was synthesized by the method of Tor et al. 2 Thin-layer chromatography was carried out on Merck coated plates 60F 254 . Silica gel column chromatography was performed with Wako gel C-400 HG silica gel. 1 To a solution of 2'-deoxy-5-methylisocytidine (1.13 g, 5 mmol) in dry DMF (24 mL) was added N,N-di-n-butylformamide dimethyl acetal (1.76 mL, 7.5 mmol). After the mixture was stirred for 45 min at r.t., the reaction was quenched with methanol. The solvent was removed under reduced pressure and the residue was purified by column chromatography (0-6% methanol in CHCl 3 ) to give 1 as a colorless solid (1.58 g, 83% ).
2'-Deoxy-5'-O-(4,4'-dimethoxytrityl)-2-{[N,N-di(n-butyl)amino]methylidene}amino-5-me thylisocytidine 3'-O-(2-cyanoethyl diisopropylphosphoramidite) (3).
To a solution of compound 2 (3.6 g, 5.3 mmol) in dry CH 2 
Oligonucleotide synthesis and characterization with MALDI-TOF mass
Oligodeoxyribonucleotides were synthesized on an Applied Biosystems model 392 automated DNA/RNA synthesizer. Reagents for the synthesizer, other than 5-methylisocytosine phosphramidite, were purchased from Applied Biosystems Japan. Deprotection of oligomers containing 2'-deoxy-5-methyisocytidine were performed by prolonged treatment with concentrated aqueous ammonia at 55°C for 16 h for completion of deprotection of the di(n-butyl)formamidine group. 
UV melting experiments
Duplex solutions (5 μM) in 1 M NaClO 4 , 10 mM MOPS, pH 7.1 were heated at 90ºC and cooled gradually to room temperature. Melting curves were measured at least twice at 270 nm on a JASCO V-560 spectrophotometer equipped with a programmable temperature control unit. The temperature was raised at a rate of 0.5ºC/min. To obtain T m values, melting curve data were fitted using the Meltwin program 3 (version 3.5), assuming a two-state transition of two non-self-complementary oligonucleotides. 
